Regenacy
PrivateLast Round
Series B
Aug 24, 2022
Total Funding Raised
$39.3M
Company Overview
Regenacy Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutic drugs that employ a novel, disease-modifying approach for treating peripheral neuropathy and related conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenacy Comps
Public and private peers based on sector, stage, and business model.
Regenacy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 24, 2022 | ||||
| Series A | Mar 25, 2020 |
Regenacy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yonjin Capital | Series A |
| Viva Biotech | Series A |
| TA YA VENTURE HOLDINGS LIMITED | Series A |
| Cobro Ventures | Series A, Series B |
Regenacy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regenacy's valuation, stock price, and market status.
